1. Home
  2. POOL vs RDY Comparison

POOL vs RDY Comparison

Compare POOL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pool Corporation

POOL

Pool Corporation

HOLD

Current Price

$264.99

Market Cap

9.9B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.70

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POOL
RDY
Founded
1993
1984
Country
United States
India
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
11.6B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
POOL
RDY
Price
$264.99
$13.70
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$308.57
$16.90
AVG Volume (30 Days)
759.6K
1.5M
Earning Date
02-19-2026
01-20-2026
Dividend Yield
1.89%
0.52%
EPS Growth
N/A
5.58
EPS
10.93
0.76
Revenue
$5,294,666,000.00
$3,848,694,754.00
Revenue This Year
$1.92
$6.12
Revenue Next Year
$3.49
$2.58
P/E Ratio
$24.25
$17.77
Revenue Growth
N/A
11.09
52 Week Low
$226.10
$12.26
52 Week High
$374.74
$16.17

Technical Indicators

Market Signals
Indicator
POOL
RDY
Relative Strength Index (RSI) 65.25 52.40
Support Level $258.50 $12.82
Resistance Level $269.96 $13.95
Average True Range (ATR) 6.74 0.23
MACD 2.33 0.02
Stochastic Oscillator 86.76 68.20

Price Performance

Historical Comparison
POOL
RDY

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: